
Dr. Harald König
- Scientific staff
- Research group “Life, Innovation, Health, and Technology”
- Room: 230.1
- Phone: +49 721 608-23293
- h koenigShg9∂kit edu
Institut für Technikfolgenabschätzung und Systemanalyse (ITAS)
Postfach 3640
76021 Karlsruhe
Fields of work
- Technology assessement of biosciences
- Risk-benefit analysis of emerging biotechnologies such as synthetic biology and genome editing
- Governance of emerging biotechnologies
Professional background
1982 - 1989 | Studies in Biology, Diploma degree, University of Karlsruhe |
1989 - 1992 | Ph.D. in Biology, University of Karlsruhe |
1992 - 1994 | Postdoctoral fellow at the Centre for Molecular Biology Heidelberg (ZMBH) |
1995 - 1999 | Research associate at the Institute of Toxicology and Genetics, Karlsruhe Research Centre |
1999 | Habilitation in Genetics, University of Karlsruhe |
1999 - 2010 | Lecturer (“Privatdozent”) at the Faculty for Chemistry and Biological Sciences, University of Karlsruhe and Karlsruhe Institute of Technology |
1999 - 2011 | Independent research group leader at the Institute of Toxicology and Genetics, Karlsruhe Research Centre and Karlsruhe Institute of Technology |
Publications
2021
Reports/Preprints
König, H.; Heyen, N. B.; Baumann, M.; Schmoch, U.; Bachlechner, D.; Heil, R.; Hüsing, B.
Künstliche Intelligenz in der genomischen Medizin – Potenziale und Handlungsbedarf.
2021. Institut für Technikfolgenabschätzung und Systemanalyse (ITAS)
Künstliche Intelligenz in der genomischen Medizin – Potenziale und Handlungsbedarf.
2021. Institut für Technikfolgenabschätzung und Systemanalyse (ITAS)
2020
Reports/Preprints
König, H.
Artificial intelligence in human genomics: Mapping research and existing and emerging applications.
2020. Institut für Technikfolgenabschätzung und Systemanalyse (ITAS). doi:10.5445/IR/1000130769
Artificial intelligence in human genomics: Mapping research and existing and emerging applications.
2020. Institut für Technikfolgenabschätzung und Systemanalyse (ITAS). doi:10.5445/IR/1000130769
2019
Journal Articles
König, H.
Germline-editing moratorium — why we should resist it.
2019. Nature <London>, 568 (458), 1. doi:10.1038/d41586-019-01292-6
Germline-editing moratorium — why we should resist it.
2019. Nature <London>, 568 (458), 1. doi:10.1038/d41586-019-01292-6
Audio & Video
Fuchs, S.; König, H., [Interviewter].
Dr. Computer - Chancen und Risiken des Einsatzes Künstlicher Intelligenz in der Medizin - Campusreport am 12.03.2019.
2019. doi:10.5445/DIVA/2019-195
Dr. Computer - Chancen und Risiken des Einsatzes Künstlicher Intelligenz in der Medizin - Campusreport am 12.03.2019.
2019. doi:10.5445/DIVA/2019-195
2018
Journal Articles
Bolz, K.; König, H.
Can responsible innovation be a moderator of entrepreneurship? - Learnings from the debate on advanced biotechnology.
2018. International journal of business and globalisation, 21 (3), 308–326. doi:10.1504/IJBG.2018.10016576
Can responsible innovation be a moderator of entrepreneurship? - Learnings from the debate on advanced biotechnology.
2018. International journal of business and globalisation, 21 (3), 308–326. doi:10.1504/IJBG.2018.10016576
2017
Books
Heil, R.; Seitz, S. B.; König, H.; Robienski, J. (Eds.).
Epigenetics - Ethical, legal and social aspects.
2017. VS Verlag für Sozialwissenschaften
Epigenetics - Ethical, legal and social aspects.
2017. VS Verlag für Sozialwissenschaften
Journal Articles
König, H.
Brave New Genomes.
2017. Zeitschrift für Technikfolgenabschätzung in Theorie und Praxis : TATuP, 26 (1-2), 84 85. doi:10.14512/tatup.26.1-2.84
Brave New Genomes.
2017. Zeitschrift für Technikfolgenabschätzung in Theorie und Praxis : TATuP, 26 (1-2), 84 85. doi:10.14512/tatup.26.1-2.84
König, H.
The illusion of control in germline-engineering policy.
2017. Nature biotechnology, 35 (6), 502–506. doi:10.1038/nbt.3884
The illusion of control in germline-engineering policy.
2017. Nature biotechnology, 35 (6), 502–506. doi:10.1038/nbt.3884
Presentations
König, H.
When synbio met society - Some lessons learned.
2017. European Summit of Industrial Biotechnology (esib) (2017), Graz, Austria, November 14–16, 2017
When synbio met society - Some lessons learned.
2017. European Summit of Industrial Biotechnology (esib) (2017), Graz, Austria, November 14–16, 2017
König, H.
When synbio meets society - some lessons learned.
2017. European Summit of Industrial Biotechnology (ESIB), Graz, A, November 14-16, 2017
When synbio meets society - some lessons learned.
2017. European Summit of Industrial Biotechnology (ESIB), Graz, A, November 14-16, 2017
König, H.
Technologie::Leben - Neue Chancen, neue Herausforderungen.
2017. Deutsche Biotechnologietage 2017, Hannover, 5.-6.April 2017
Technologie::Leben - Neue Chancen, neue Herausforderungen.
2017. Deutsche Biotechnologietage 2017, Hannover, 5.-6.April 2017
König, H.
Designed biological systems meet society: challenges for science and applications.
2017. CompuGene Symposium on Computer-aided Engineering of Synthetic Genetic Circuits, Darmstadt, June 19-21, 2017
Designed biological systems meet society: challenges for science and applications.
2017. CompuGene Symposium on Computer-aided Engineering of Synthetic Genetic Circuits, Darmstadt, June 19-21, 2017
2016
Book Chapters
Heil, R.; Seitz, S. B.; Robienski, J.; König, H.
Einleitung - Epigenetik : Ethische, rechtliche und soziale Aspekte.
2016. Epigenetik : Ethische, rechtliche und soziale Aspekte. Hrsg.: R. Heil, 7–14, VS Verlag für Sozialwissenschaften
Einleitung - Epigenetik : Ethische, rechtliche und soziale Aspekte.
2016. Epigenetik : Ethische, rechtliche und soziale Aspekte. Hrsg.: R. Heil, 7–14, VS Verlag für Sozialwissenschaften
König, H.; Frank, D.; Heil, R.; Coenen, C.
Synthetic biology’s multiple dimensions of benefits and risks: implications for governance and policies.
2016. Synthetic Biology : Metaphors, Worldviews, Ethics, and Law. Ed.: J. Boldt, 217–232, VS Verlag für Sozialwissenschaften. doi:10.1007/978-3-658-10988-2_14
Synthetic biology’s multiple dimensions of benefits and risks: implications for governance and policies.
2016. Synthetic Biology : Metaphors, Worldviews, Ethics, and Law. Ed.: J. Boldt, 217–232, VS Verlag für Sozialwissenschaften. doi:10.1007/978-3-658-10988-2_14
Books
Heil, R.; Seitz, S. B.; König, H.; Robienski, J. (Eds.).
Epigenetik : Ethische, rechtliche und soziale Aspekte.
2016. VS Verlag für Sozialwissenschaften
Epigenetik : Ethische, rechtliche und soziale Aspekte.
2016. VS Verlag für Sozialwissenschaften
Journal Articles
König, H.; Frank, D.
Von der Invention zur Innovation: Anwendungspotenziale von Synthetischer Biologie und Genome Editing [Nachdruck].
2016. umwelt medizin gesellschaft, 29 (3), 35–40
Von der Invention zur Innovation: Anwendungspotenziale von Synthetischer Biologie und Genome Editing [Nachdruck].
2016. umwelt medizin gesellschaft, 29 (3), 35–40
Presentations
Bolz, K.; König, H.
Responsible innovation as a moderator of entrepreneurship - Learnings from the debate on advanced biotechnology.
2016. The Co-Production of Emerging Bodies, Politics and Technologies : 8th Annual S.Net Meeting, Bergen, N, October 12-14, 2016
Responsible innovation as a moderator of entrepreneurship - Learnings from the debate on advanced biotechnology.
2016. The Co-Production of Emerging Bodies, Politics and Technologies : 8th Annual S.Net Meeting, Bergen, N, October 12-14, 2016
2015
Book Chapters
Albrecht, S.; Coenen, C.; König, H.
Enriching the methodological scope of technology assessment. Initial insights from SYNENERGENE, the mobilisation and mutual learning action plan on synthetic biology.
2015. The next horizon of technology assessment : Proceedings from the PACITA 2015 Conference in Berlin. Ed.: C. Scherz, 151–156, Technology Centre ASCR
Enriching the methodological scope of technology assessment. Initial insights from SYNENERGENE, the mobilisation and mutual learning action plan on synthetic biology.
2015. The next horizon of technology assessment : Proceedings from the PACITA 2015 Conference in Berlin. Ed.: C. Scherz, 151–156, Technology Centre ASCR
Journal Articles
Frank, D.; Heil, R.; Coenen, C.; König, H.
Synthetic biology’s self-fulfilling prophecy - dangers of confinement from within and outside.
2015. Biotechnology journal, 10 (2), 231–235. doi:10.1002/biot.201400477
Synthetic biology’s self-fulfilling prophecy - dangers of confinement from within and outside.
2015. Biotechnology journal, 10 (2), 231–235. doi:10.1002/biot.201400477
König, H.; Frank, D.
Von der Invention zur Innovation: Anwendungspotenziale von synthetischer Biologie und Genome Editing.
2015. TAB-Brief, (46), 5–12
Von der Invention zur Innovation: Anwendungspotenziale von synthetischer Biologie und Genome Editing.
2015. TAB-Brief, (46), 5–12
König, H.; Dorado-Morales, P.; Orcar, M.
Responsibility and intellectual property in synthetic biology: A proposal for using Responsible Research and Innovation as a basic framework for intellectual property decisions in synthetic biology.
2015. EMBO reports, 16 (9), 1055–1059. doi:10.15252/embr.201541048
Responsibility and intellectual property in synthetic biology: A proposal for using Responsible Research and Innovation as a basic framework for intellectual property decisions in synthetic biology.
2015. EMBO reports, 16 (9), 1055–1059. doi:10.15252/embr.201541048
Reports/Preprints
Sauter, A.; Albrecht, S.; van Doren, D.; König, H.; Reiß, T.; Trojok, R.; Elsbach, S.
Synthetische Biologie - die nächste Stufe der Bio- und Gentechnologie. Endbericht zum TA-Projekt.
2015. Endbericht zum TA-Projekt TAB Arbeitsbericht Nr.164 (November 2015), Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag (TAB)
Synthetische Biologie - die nächste Stufe der Bio- und Gentechnologie. Endbericht zum TA-Projekt.
2015. Endbericht zum TA-Projekt TAB Arbeitsbericht Nr.164 (November 2015), Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag (TAB)
Presentations
Albrecht, S.; Coenen, C.; König, H.
Enriching the methodological scope of prospective technology assessment. First impressions from SYNENERGENE, the ’Mobilisation and Mutual Learning Action Plan’ on synthetic biology.
2015. 2nd European TA Conference, Berlin, February 25-27, 2015
Enriching the methodological scope of prospective technology assessment. First impressions from SYNENERGENE, the ’Mobilisation and Mutual Learning Action Plan’ on synthetic biology.
2015. 2nd European TA Conference, Berlin, February 25-27, 2015
Coenen, C.; Albrecht, S.; König, H.
Making sense of RRI in the SYNENERGENE project.
2015. 2nd European TA Conference, Berlin, February 25-27, 2015
Making sense of RRI in the SYNENERGENE project.
2015. 2nd European TA Conference, Berlin, February 25-27, 2015
2014
Conference Papers
König, H.; Coenen, C.; Frank, D.; Heil, R.
Science, technology and the state: Implications for governance of synthetic biology and emerging technologies.
2014. Technology Assessment and Policy Areas of Great Transitions : Proceedings from the PACITA 2013 Conference, Praha, CZ, March 13-15, 2013. Ed.: T. Michalek, 315–320, Technology Centre ASCR
Science, technology and the state: Implications for governance of synthetic biology and emerging technologies.
2014. Technology Assessment and Policy Areas of Great Transitions : Proceedings from the PACITA 2013 Conference, Praha, CZ, March 13-15, 2013. Ed.: T. Michalek, 315–320, Technology Centre ASCR
Presentations
Coenen, C.; König, H.
SYNENERGENE - Responsible research and innovation in synthetic biology.
2014. Workshop on Research Agendas in the Societal Aspects of Synthetic Biology an der Arizona State University (2014), Tempe, AZ, USA, November 4–6, 2014
SYNENERGENE - Responsible research and innovation in synthetic biology.
2014. Workshop on Research Agendas in the Societal Aspects of Synthetic Biology an der Arizona State University (2014), Tempe, AZ, USA, November 4–6, 2014
König, H.
Ethics, responsibility and synthetic biology.
2014. Biology feat. Engineering - Symposium der International Autumn School on Synthetic Biology (2014), Marburg, Germany, November 24–25, 2014
Ethics, responsibility and synthetic biology.
2014. Biology feat. Engineering - Symposium der International Autumn School on Synthetic Biology (2014), Marburg, Germany, November 24–25, 2014
2013
Journal Articles
König, H.; Frank, D.; Heil, R.; Coenen, C.
Synthetic genomics and synthetic biology applications between hopes and concerns.
2013. Current Genomics, 14, 11–24. doi:10.2174/1389202911314010003
Synthetic genomics and synthetic biology applications between hopes and concerns.
2013. Current Genomics, 14, 11–24. doi:10.2174/1389202911314010003
Presentations
Heil, R.; König, H.; Robienski, J.
Epigenetik - Können wir unsere Gene beeinflussen?.
2013. Klausurwoche Epigenetik, Karlsruhe, 16.-21. September 2013
Epigenetik - Können wir unsere Gene beeinflussen?.
2013. Klausurwoche Epigenetik, Karlsruhe, 16.-21. September 2013
Heil, R.; König, H.; Robienski, J.
Klausurwoche Epigenetik.
2013. Klausurwoche Epigenetik, Karlsruhe, 16.-21. September 2013
Klausurwoche Epigenetik.
2013. Klausurwoche Epigenetik, Karlsruhe, 16.-21. September 2013
König, H.; Coenen, C.; Frank, D.; Heil, R.
Science, technology and the state: The quest for knowledge-based governance in synthetic biology.
2013. 1st PACITA Conference on Technology Assessment and Policy Areas of Great Transitions, Praha, CZ, March 13-15, 2013
Science, technology and the state: The quest for knowledge-based governance in synthetic biology.
2013. 1st PACITA Conference on Technology Assessment and Policy Areas of Great Transitions, Praha, CZ, March 13-15, 2013
Posters
Ferrari, A.; Frank, D.; Heil, R.; König, H.; Weinberger, N.
Nutzen und Risiken des Tissue Engineering.
2013. ITA-Forum ’Innovations- und Technikanalyse im Dialog’, Berlin, 26.-27. September 2013
Nutzen und Risiken des Tissue Engineering.
2013. ITA-Forum ’Innovations- und Technikanalyse im Dialog’, Berlin, 26.-27. September 2013
2012
Presentations
König, H.; Coenen, C.
New science, new risks, new governance? Prospects and policy directions.
2012. Visions of Synthetic Biology : 2nd Workshop of SynBioTA, Bremen, June 27-29, 2012
New science, new risks, new governance? Prospects and policy directions.
2012. Visions of Synthetic Biology : 2nd Workshop of SynBioTA, Bremen, June 27-29, 2012